Actively Recruiting

Early Phase 1
Age: 18Years +
All Genders
NCT05365802

FAPI PET for Lung Fibrosis

Led by University of California, Los Angeles · Updated on 2025-07-03

30

Participants Needed

1

Research Sites

263 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD). The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic lung tissues of patients with interstitial lung disease. The study will include patients with interstitial lung disease who have or will initiate a new ILD medication OR will undergo tissue biopsy or surgery of the lung. The study will include 30 patients, the upper limit for PET imaging studies conducted under the Radioactive Drug Research Committee (RDRC) purview. Participants will be injected with up to 7 mCi of 68-GaFAPi and will undergo one PET/CT scan and one High Resolution CT of the lungs. The study is sponsored by Ahmanson Translational Theranostic Division at UCLA.

CONDITIONS

Official Title

FAPI PET for Lung Fibrosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with interstitial lung disease confirmed by CT scan at time of staging
  • Patients who have started or will start a new ILD medication within 3 months of enrollment OR patients scheduled for lung biopsy or surgery
  • Patients aged 18 years or older at time of radiotracer administration
  • Patients able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Pregnant or nursing patients
  • Patients with active infectious lung disease
  • Patients unable or unwilling to comply with study procedures or understand the trial requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States, 90095

Actively Recruiting

Loading map...

Research Team

S

Stephanie Lira

CONTACT

C

Contreras M Maria, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here